臨床試驗

REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active Men

NCT：NCT04838769 · ACTIVE_NOT_RECRUITING

NCT IDNCT04838769

狀態ACTIVE_NOT_RECRUITING

開始日期2021-09-15

SponsorBoston Scientific Corporation (INDUSTRY)

First posted2021-04-09

Last updated2026-09-14

簡要摘要

The study objective is to compare water vapor thermotherapy with the REZŪM™ System to dual drug therapy for the treatment of symptomatic benign prostatic hyperplasia refractory to alpha-blocker monotherapy in sexually active men.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。